The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.
[EN] NOVEL SULFONAMINOQUINOLINE HEPCIDIN ANTAGONISTS<br/>[FR] NOUVEAUX ANTAGONISTES DE SULFONAMINOQUINOLINE-HEPCIDINE
申请人:VIFOR INT AG
公开号:WO2012110603A1
公开(公告)日:2012-08-23
The present invention relates to novel hepcidin antagonists of formula (I), pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anaemias, in particular anaemias in connection with chronic inflammatory diseases (ACD: anaemia of chronic disease and Al; anaemia of inflammation).
Zur Synthese sulfonierter Derivate von 2,3-Dimethylanilin und 3,4-Dimethylanilin
作者:Alfred Courtin、Hans-Rudolf Von Tobel
DOI:10.1002/hlca.19800630208
日期:1980.3.5
On the Synthesis of Sulfonated Derivatives of 2,3-Dimethylaniline and 3,4-Dimethylaniline